Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02539433 · ClinicalTrials.gov registry record · NA
Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA)
A NA study, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT02539433 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 22 participants.
The verdict
NCT02539433, a NA study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Imaging of neuroendocrine (NETs), such as carcinoids and pheochromocytomas (PHEOs), is suboptimal, limiting curative treatment. The investigators wanted to explore the use of PET and F-DOPA i.v. for the localization of these types of neoplasms. The investigators used a similar protocol as they had used for PET (Positron emission tomography) or FDG (Fludeoxyglucose) imaging in oncologic patients. F-DOPA, prepared according to United States Pharmacopeia (USP) guidelines, was approved by the North Shore University Hospital Radiation Safety Committee in 1989 and 1994 for the study of neurological diseases and used uneventfully.
Interventions
- PROCEDURE F-18-F-DOPA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2003-12 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02539433
The ClinicalTrials.gov registry entry for NCT02539433 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which F-18-F-DOPA is the first listed.
NCT02539433 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02539433 about?
NCT02539433 is a clinical study titled "Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA)". Imaging of neuroendocrine (NETs), such as carcinoids and pheochromocytomas (PHEOs), is suboptimal, limiting curative treatment. The investigators wanted to explore the use of PET and F-DOPA i.v. for the localization of these types of neoplasms. The investigators used a similar protocol as they had u...
What is the current status of trial NCT02539433?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2003-12. Estimated completion is 2015-05.
What interventions are being tested in trial NCT02539433?
The interventions under investigation include: F-18-F-DOPA (PROCEDURE).
Who is sponsoring clinical trial NCT02539433?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.